Policy & Advocacy
AlzInColor Urges Congress to Pass the ASAP Act, Backed by More Than 2,000 Signatures
AlzInColor is raising the volume on equitable access to Alzheimer's screening and early detection. On November 9, 2026, we submitted a letter to members of Congress urging passage of the bipartisan Alzheimer's Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267), supported by 2,033 signatures from across 52 states and territories.
The letter highlights the disproportionate impact of Alzheimer's disease on Black and Latino communities and calls for expanded Medicare coverage of FDA-cleared blood-based biomarker tests. These advances could help address barriers to earlier detection and provide families with more opportunities to plan, seek care, and access support.
Through this collective advocacy effort, AlzInColor is amplifying community voices and calling attention to the importance of ensuring that advances in Alzheimer's detection and care are accessible to all.
Read the full letter here.


Join AlzInColor in advocating for equitable access to early Alzheimer’s detection and care. Learn how the bipartisan ASAP Act could expand Medicare coverage for FDA-cleared blood-based screening tests and help Black and Latino families get answers sooner. Sign and share our community petition by October 30, 2026!












